Jason Karlawish

Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

Yasser Iturria‐Medina, Roberto C. Sotero, P.-J. Toussaint et al. · Nature Communications · 2016 · 1.2K citations · Full text

Life Sciences, Neurology, Neuroscience +17

The A4 Study: Stopping AD Before Symptoms Begin?

Reisa A. Sperling, Dorene M. Rentz, Keith A. Johnson et al. · Science Translational Medicine · 2014 · 771 citations · Full text

Medicine, Geriatric Medicine, Neurology +17

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease

Raymond Scott Turner, Ronald G. Thomas, Suzanne Craft et al. · Neurology · 2015 · 699 citations · Full text

Medicine, Neurology, Neuroscience +15

Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

Keith A. Johnson, Satoshi Minoshima, Nicolaas I. Bohnen et al. · Alzheimer s & Dementia · 2013 · 596 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference

Alexandra L. Young, Razvan Marinescu, Neil P. Oxtoby et al. · Nature Communications · 2018 · 586 citations · Full text

Medicine, Neurology, Neuroscience +17